Effect of Dietary Carnitine Isomers and γ-Butyrobetaine on L-Carnitine Biosynthesis and Metabolism in the Rat
- 1 October 1983
- journal article
- research article
- Published by Elsevier in Journal of Nutrition
- Vol. 113 (10) , 1906-1913
- https://doi.org/10.1093/jn/113.10.1906
Abstract
Oral supplementation with L-carnitine or DL-carnitine for treatment of primary and secondary carnitine deficiency syndromes is becoming increasingly popular, yet little is known about the systemic manifestations of oral intake of large doses of those compounds, particularly the D-isomer of carnitine. To determine the possible beneficial and/or toxic effects or oral carnitine isomers and the carnitine precursor, γ-butyrobetaine, in the rat, groups of male, weanling rats were fed a carnitine-free diet (control) supplemented with various amounts of L-carnitine, D-carnitine, DL-carnitine or γ-butyrobetaine for 32 days. Rats fed diets supplemented with L-carnitine (0.1–1.0%) had increased L-carnitine concentrations in serum and all tissues studied. Mean L-carnitine concentrations in serum and tissues (except liver) from rats fed equivalent amounts of L-carnitine, as the racemic mixture DL-carnitine, were greater than controls but were consistently lower than in rats fed L-carnitine alone. D-Carnitine (1% of diet) significantly reduced serum and heart L-carnitine concentrations from control levels, and the effects of γ-butyrobetaine depended on the level of dietary supplementation. Dietary L-carnitine, D-carnitine and γ-butyrobetaine (1%) reduced carnitine biosynthesis from ε-N-trimethyl-L-lysine in vivo. However, this decrease probably resulted from effects on transport of γ-butyrobetaine into tissues, rather than on the biosynthetic pathway per se. Other than mild diarrhea with high levels of some supplements, no toxic effects of these compounds were observed under the conditions employed and within the time frame of the study. However, the negative effects of high levels of dietary γ-butyrobetaine and D-carnitine on tissue L-carnitine concentrations observed in this study may presage more severe systemic alterations over a longer period of time.Keywords
This publication has 26 references indexed in Scilit:
- Carnitine deficiency presenting as familial cardiomyopathy: A treatable defect in carnitine transportThe Journal of Pediatrics, 1982
- Tissue specific depletion of L-carnitine in rat heart and skeletal muscle by D-carnitineLife Sciences, 1981
- Systemic Carnitine Deficiency — A Treatable Inherited Lipid-Storage Disease Presenting as Reye's SyndromeNew England Journal of Medicine, 1980
- Properties of carnitine transport in rat kidney cortex slicesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1980
- Transport and metabolism of carnitine precursors in various organs of the ratBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- Tissue distribution of carnitine biosynthetic enzymes in manBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- CARNITINE DEFICIENCY INDUCED DURING INTERMITTENT HÆMODIALYSIS FOR RENAL FAILUREThe Lancet, 1978
- Carnitine movement across muscle cell membranes. Studies in isolated rat muscleBiochimica et Biophysica Acta (BBA) - Biomembranes, 1977
- Carnitine synthesis in rat tissue slicesBiochemical and Biophysical Research Communications, 1974
- Carnitine depletion in the choline-deficient stateBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1967